The major US stock indexes opened lower this morning following a weak report on non-farm payrolls (our coverage here). The lack of any further data to chew over left the markets with nothing to do...
Source: Jon OggThe top analyst upgrades, downgrades and initiations seen in Wall St. research calls will be playing catch-up on Wednesday as the markets did not get a chance to react to the analyst...
U.S. equity markets opened higher this morning following the report on U.S. non-farm payrolls and the U.S. unemployment rate. Payrolls rose by 171,000, better than expected, and the unemployment rate...
U.S. equity markets opened mixed this morning as investors appear to be cautious as tomorrow’s elections get closer. Coupled with possible changes in the U.S., China will replace its leadership at...
(ABAX) Abaxis announces CLIA waived status for two additional medical test panels.(AMZN) Amazon.com’s partnership at Borders is being terminated.(ARWR) Arrowhead Research subsidiary Unidym to merge...
(ADSK) Autodesk trading down 0.7% after trading higher initially on earnings yesterday.(AQNT) aQuantive gets a $66.50 buyout price from Microsoft, nearly a 90% premium.(APD) Air Products is in CEO...
Arrowhead Pharmaceuticals shares plummeted early on Wednesday after the company gave an update on its hepatitis B virus treatment.
December 12, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Monday’s session. On the NYSE, decliners led advancers by nearly 2 to 1...
November 30, 2016: Here are four stocks trading with relatively heavy volume among 62 equities making new 52-week lows in Wednesday’s session. On the NYSE, decliners led advancers by about 3 to...
December 20, 2016: Here are four stocks trading with relatively heavy volume among 51 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 2 to 1...
Source: ThinkstockOctober 8, 2014: The following stocks are among the 469 equities making new 52-week lows today:Arrowhead Research Corp. (NASDAQ: ARWR) dropped about 56% Wednesday to a new 52-week...
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday. 
Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.
Arrowhead Pharmaceuticals shares made a considerable gain early on Thursday after the firm announced data from its hepatitis B clinical trial with ARO-HBV.
Arrowhead Research made waves in the market on Friday afternoon on positive developments surrounding its ARC-HIF2.